Annovis Bio

ANVSNYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$65.136 M

$1.88 +1.07%

Close of 7 Aug 2026

Revenue

$0.00

#3658 by revenue

Earnings

-$28.9M

Loss-making

Shares outstanding

28,355,262

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#336CleneCLNN$67.5M
#337MedicinovaMNOV$66.0M
#338Annovis BioANVS$65.1M
#339Pliant TherapeuticsPLRX$65.0M
#340Boundless BioBOLD$64.9M

Where these numbers come from

Share counts and financials for Annovis Bio are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.